EAACI Congress 2025

Back
13 - 16 June 2025 Glasgow, United Kingdom

Long-term safety of garadacimab in patients with hereditary angioedema from the Phase 3 open-label extension study: an up to 3-year interim analysis

Friday 13 Jun, 17:20 PM - 17:27 PM Glasgow, United Kingdom